Treatment of Atrophic Acne Scars With a Fractional CO2 Laser at 1 Versus 3 Months Intervals
2 other identifiers
interventional
12
1 country
1
Brief Summary
To compare efficacy and adverse effects of fractional CO2 laser of acne scars treatment with 1 versus 3 months intervals
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at below P25 for not_applicable
Started Nov 2011
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
November 1, 2011
CompletedPrimary Completion
Last participant's last visit for primary outcome
January 1, 2013
CompletedStudy Completion
Last participant's last visit for all outcomes
January 1, 2013
CompletedFirst Submitted
Initial submission to the registry
January 2, 2013
CompletedFirst Posted
Study publicly available on registry
January 23, 2013
CompletedJanuary 23, 2013
January 1, 2013
1.2 years
January 2, 2013
January 18, 2013
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
Change in scar texture
24 weeks
Secondary Outcomes (1)
Appearance of erythema, oedema, pigmentation, infection
24 weeks
Study Arms (2)
CO2 laser at 1 month interval
ACTIVE COMPARATORCO2 laser treatment of mild to severe acne scars at 1 month interval
CO2 laser at 3 monrths interval
ACTIVE COMPARATORCO2 laser treatment of mild to severe acne scars at 3 month intervals
Interventions
Fractionel CO2 laser: 1 versus 3 months intervals
Eligibility Criteria
You may qualify if:
- Have Fitzpatrick skin type I-III. (•Are male or female.
- Are between 18 and 60 years of age.
- Mild to severe acne scarring.
- Are able to read, understand, and sign the Informed Consent.
- Are willing and able to comply with all follow-up requirements -
You may not qualify if:
- Have had active localized or systemic infections within 6 months of enrollment
- Have compromised ability for wound healing, such as: malnutrition, oral steroid use, history of collagen vascular disease (e.g. lupus, scleroderma, history of keloid formation (raised and thickened scars), atrophic dermatitis (extreme skin irritation or itchiness) or immunologic abnormalities such as vitiligo (white patches of skin due to loss of pigment)
- Have been treated with lasers, chemical procedures, or other cosmetic procedures on the area to be treated within 6 months of enrollment
- Pregnancy
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
Aarhus University Hospital
Aarhus, Aarhus C, 8000, Denmark
MeSH Terms
Interventions
Intervention Hierarchy (Ancestors)
Study Officials
- STUDY DIRECTOR
Lene Hedelund, MD, PhD
Aarhus University Hospital
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- SINGLE
- Who Masked
- OUTCOMES ASSESSOR
- Purpose
- TREATMENT
- Intervention Model
- PARALLEL
- Sponsor Type
- OTHER
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
January 2, 2013
First Posted
January 23, 2013
Study Start
November 1, 2011
Primary Completion
January 1, 2013
Study Completion
January 1, 2013
Last Updated
January 23, 2013
Record last verified: 2013-01